Citation Impact
Citing Papers
The Role of Innate and Adaptive Immunity in Parkinson's Disease
2013
Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate model
2009
Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease
2006
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Astrocytes: biology and pathology
2009 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
2020 Standout
Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases
2016
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
Parkinson disease
2017 Standout
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
2007 Standout
European Resuscitation Council Guidelines for Resuscitation 2010 Section 2. Adult basic life support and use of automated external defibrillators
2010 Standout
A Review on Central Nervous System Effects of Gastrodin
2018 Standout
Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys
2005
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
Structure and function of the blood–brain barrier
2009 Standout
The extracellular matrix as a scaffold for tissue reconstruction
2002 Standout
Occupational factors and risk of Parkinson's disease: A population‐based case–control study
2009
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Caffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum
2008
Microglial cell origin and phenotypes in health and disease
2011 Standout
Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells
2010 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
2018
Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders
2006
Novel investigational adenosine A2Areceptor antagonists for Parkinson's disease
2009
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
2014
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
2011 Standout
Glial reactions in Parkinson's disease
2007
Expression levels of vascular endothelial growth factor and its receptors in Parkinson's disease
2006
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
2015 Standout
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
The blood–brain barrier in neurodegenerative disease: a rhetorical perspective
2009
Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease
2013
Parkinson's disease
2015 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
2007 Standout
Inflammation, the complement system and the diseases of aging
2005
Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease
2006
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration
2006
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Functional mapping and annotation of genetic associations with FUMA
2017 Standout
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease
2014
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
2007 Standout
Parkinson's Disease as a Neuroendocrine Disorder of Circadian Function: Dopamine-Melatonin Imbalance and the Visual System in the Genesis and Progression of the Degenerative Process
2008
Elusive roles for reactive astrocytes in neurodegenerative diseases
2015
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
2007
Non-motor features of Parkinson disease
2017 Standout
Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy
2011
Reactive Astrocytes: Production, Function, and Therapeutic Potential
2017 Standout
Oxidative and Inflammatory Pathways in Parkinson’s Disease
2008
Creutzfeldt–Jakob disease via dural and corneal transplants
1998
Etiology and pathogenesis of Parkinson's disease
2011
Spectroscopy and serial diffusion MR findings in hGH-Creutzfeldt-Jakob disease
2004
Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1β in the substantia nigra
2006
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
2009
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Porcine small intestinal submucosa as a dural substitute
1999
Involvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons
2007
Three-dimensional culture of annulus fibrosus cells within PDLLA/Bioglass® composite foam scaffolds: Assessment of cell attachment, proliferation and extracellular matrix production
2007
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson’s disease
2006
Endothelial Proliferation and Increased Blood–Brain Barrier Permeability in the Basal Ganglia in a Rat Model of 3,4-Dihydroxyphenyl-l-Alanine-Induced Dyskinesia
2006
Neuroinflammation: the devil is in the details
2016 Standout
NF-κB in Aging and Disease.
2011 Standout
The Beneficial Role of Thiamine in Parkinson Disease
2013
Neuroimmunological Processes in Parkinson’s Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity
2013
Bioactive Glass and Glass-Ceramic Scaffolds for Bone Tissue Engineering
2010 Standout
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Infections Acquired during Cardiopulmonary Resuscitation: Estimating the Risk and Defining Strategies for Prevention
1998
Increased CSF biomarkers of angiogenesis in Parkinson disease
2015
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Blood–Brain Barrier Pathology in Alzheimer's and Parkinson's Disease: Implications for Drug Therapy
2007
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
2016 Standout
Microglial M1/M2 polarization and metabolic states
2015 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Neurotoxins and neurotoxic species implicated in neurodegeneration
2004
Reduced Vascular Endothelial Growth Factor and Capillary Density in the Occipital Cortex in Dementia with L ewy Bodies
2014
Rotenone, Paraquat, and Parkinson’s Disease
2011 Standout
Works of M. Poza being referenced
Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure
2004
Lumbar disc herniation in early childhood: case report and literature review
2003
Parkinson's disease and inflammatory changes
2003
Measurement of motor disability in MPTP-treated macaques using a telemetry system for estimating circadian motor activity
2004
Circadian Determinations of Cortisol, Prolactin and Melatonin in Chronic Methyl-Phenyl-Tetrahydropyridine-Treated Monkeys
2003
Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian
2005
Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts.
1994